Back
Crinetics Pharmaceuticals, Inc. (CRNX)
PharmaceuticalsCRNX · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$83.62
+0.16%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$-4.95
ROE
-39.2%
Gross margin
0.0%
Debt/Equity
3.74x
Revenue growth
2873.4%
P/B ratio
Beta
Forward P/E
Crinetics Pharmaceuticals, Inc. — company intelligence
Earnings surprises
Q1 2026$-1.23 vs $-1.26 est+2.5%
Q4 2025$-1.29 vs $-1.39 est+7.5%
Q3 2025$-1.38 vs $-1.28 est-7.8%
Q2 2025$-1.23 vs $-1.12 est-9.8%
Insider activity · 90 days
14 buys2 sellsnet +102,685 shares
Bedrosian Camille LBuy 5,925 · Jun 18, 2026
Bedrosian Camille LBuy 9,730 · Jun 18, 2026
Deardorf CarenBuy 5,925 · Jun 18, 2026
Recent SEC filings
4 — Insider transaction reportJun 22, 2026
4 — Insider transaction reportJun 22, 2026
4 — Insider transaction reportJun 22, 2026
Latest news
The trading volume of these stocks is deviating from the norm in today's session. — ChartMill · 2d ago
Biotech Euphoria Driven By Fundamentals — SeekingAlpha · 2d ago
TD Cowen Downgrades Crinetics Pharmaceuticals to Hold — Benzinga · 3d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Crinetics Pharmaceuticals, Inc.
Weekly undervalued picks (like CRNX)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.